“BEIJING—The U.S. Securities and Exchange Commission charged China Sky One Medical Inc. with falsely inflating its earnings, a rare action by the regulator almost two years after doubts about the accuracy of disclosures by small Chinese firms sent U.S. investors fleeing their stocks.
In a statement published on its website Tuesday, the SEC said that Sky One Medical, which makes Chinese medicine and was once listed on the Nasdaq Stock Market, created about $19.8 million worth of phony export sales over the course of 2007 and 2008.”
If you enjoy the content at iBankCoin, please follow us on Twitter
